ORTHOPEDIATRICS (KIDS) director receives 11,436-share stock grant, now holds 24,568

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP director George Sinclair Mitchell Dyer received an equity grant of 11,436 shares of Common Stock on June 9, 2026. The shares were acquired at no stated purchase price as a grant or award and increased his direct holdings to 24,568 shares. A footnote states that this total includes restricted stock awards of 17,959 shares, indicating a significant portion of his position is subject to vesting or other restrictions as part of his compensation.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dyer George Sinclair Mitchell

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	--

Holdings After Transaction: Common Stock — 24,568 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant: 11,436 shares Price per share: $0.00 per share Post-transaction holdings: 24,568 shares +1 more

4 metrics

Stock grant 11,436 shares Common Stock grant on June 9, 2026

Price per share $0.00 per share Grant, award, or other acquisition

Post-transaction holdings 24,568 shares Common Stock held directly after transaction

Restricted stock awards 17,959 shares Included within total direct holdings

Key Terms

Form 4, restricted stock awards, Grant, award, or other acquisition

3 terms

Form 4 regulatory

"This ORTHOPEDIATRICS director transaction was reported on Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

restricted stock awards financial

"Includes restricted stock awards totaling 17,959 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Grant, award, or other acquisition financial

"The transaction code description is Grant, award, or other acquisition."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dyer George Sinclair Mitchell

(Last) (First) (Middle)

55 ORCHARD ST.

(Street)

CAMBRIDGE MASSACHUSETTS 02140

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	24,568(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 17,959 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did ORTHOPEDIATRICS (KIDS) director George Sinclair Mitchell Dyer report on this Form 4?

George Sinclair Mitchell Dyer reported receiving a grant of 11,436 ORTHOPEDIATRICS Common Stock shares. The award was recorded at a price of $0.00 per share, indicating a compensation-related stock grant rather than an open-market purchase.

How many ORTHOPEDIATRICS (KIDS) shares does the director hold after this Form 4 transaction?

After the reported grant, the director directly holds 24,568 ORTHOPEDIATRICS Common Stock shares. This total, as disclosed, represents his post-transaction ownership and reflects the impact of the 11,436-share grant on his overall equity stake.

Was the ORTHOPEDIATRICS (KIDS) Form 4 transaction a market buy or a stock grant?

The Form 4 shows a stock grant, not a market purchase. The transaction code is “A” for grant, award, or other acquisition, and the price per share is listed as $0.00, consistent with a compensation-related equity award.

How many restricted ORTHOPEDIATRICS (KIDS) shares are included in the director’s holdings?

A footnote states that the director’s holdings include restricted stock awards totaling 17,959 shares. These restricted shares are typically subject to vesting or service conditions, aligning the director’s compensation with the company’s long-term performance.

Does this ORTHOPEDIATRICS (KIDS) Form 4 report any stock sales by the director?

No stock sales are reported in this Form 4. The filing shows one acquisition transaction coded “A” for a grant or award of 11,436 shares, with no corresponding sell or disposition transactions disclosed for the same date.